Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-35.26	118.89	183.64
Graham Fair Price	-17.03	21.71	26.17
PEG	2717.96	-3.57	0.13
Price/Book	-20.15	9.12	11.43
Price/Cash Flow	107.60	-264.68	127.49
Prices/Earnings	93.72	166.05	85.72
Price/Sales	6.99	29.74	27.80
Price/FCF	107.60	-264.68	127.49
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	24.07	0.48	0.39
Operating Margin	123.20	0.18	0.08
ROA	-51.11	< 0.005	< 0.005
ROE	0.03	0.01	-58.78
ROIC	< 0.005	0.01	199.17
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	< 0.005	-114.25
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	-0.17	1.15	598.60
EPS QOQ	6.77	-0.47	-93.13
FCF QOQ	3.03	-1.50	-50.56
Revenue QOQ	0.05	-0.04	-26.32
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	179.90	218.45	21.43
Days Sales Outstanding (DSO)	45.83	53.99	17.82
Inventory Turnover	0.50	0.41	-17.65
Debt/Capitalization	0.72	0.66	-8.92
Quick Ratio	0.62	1.19	91.93
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	30.22	39.05	29.23
Cash	5.76	16.76	190.89
Capex	-1.84	-1.88	-2.07
Free Cash Flow	2.71	-1.35	-50.30
Revenue	12.42	11.98	-3.55
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.47	2.02	37.57
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	31.72	17.11	-46.07
Naive Interpretation	Member

06 - Financial Health · Bad

Rating